- Home
- Equipment
- usa massachusetts
- metabolic disease
Show results for
Refine by
Applications
- RNA Technology for Research Fellowship
- RNA Technology for Medical Areas of Focus Research
- RNA Technology for Product Pipeline Research
- RNA Technology for Clinical trials
- Duodenal Mucosal Resurfacing System (DMR) for Type 2 Diabetes
- Duodenal Mucosal Resurfacing System (DMR) for Clinical Research Studies
- Duodenal Mucosal Resurfacing System (DMR) for T2Di Study
- Duodenal Mucosal Resurfacing System (DMR) for Healthcare Professionals
Metabolic Disease Equipment Supplied In Usa Massachusetts
6 equipment items found
by:Cartesian Therapeutics based inGaithersburg, MASSACHUSETTS (USA)
Selecta’s first ImmTORTM + gene therapy candidate MMA-101 for methylmalonic acidemia (MMA) is expected to enter clinical trials the end of 2021. MMA is a rare metabolic disease that may lead to metabolic acidosis and hyperammonemia and is associated with long-term complications including feeding problems, developmental delay, intellectual ...
Manufactured by:Boston Pharmaceuticals based inCambridge, MASSACHUSETTS (USA)
BOS-704 is a ghrelin O-acyl transferase inhibitor with therapeutic potential for multiple ...
Manufactured by:Moderna, Inc. based inCambridge, MASSACHUSETTS (USA)
At Moderna, we are delivering on the promise of mRNA science to create a new generation of transformative medicines for ...
Manufactured by:Moderna, Inc. based inCambridge, MASSACHUSETTS (USA)
Our scientists are developing mRNA medicines to help prevent or treat ...
Manufactured by:Biochrom - a division of Harvard Bioscience based inCambridge, UNITED KINGDOM
Biochrom launches the Biochrom 30+ Series of amino acid analyzers - the gold standard in dedicated amino acid analysis. Clinical laboratories worldwide trust this well documented classical amino acid analysis method based on ion exchange chromatography with post column derivatization with Ninhydrin.This allows both qualitative and quantitative analysis of up to 56 amino acids and derivatives, ...
Manufactured by:Fractyl Health based inLexington, MASSACHUSETTS (USA)
Our lead product candidate, the Revita DMR System, or Revita®, is a first-in-class procedural therapy designed to target the duodenum as a root cause of type 2 diabetes. For people with advanced type 2 diabetes, the main form of therapy to control HbA1c today is insulin dose escalation and lifestyle interventions. We have developed and are investigating Revita DMR with the goal of providing ...